Ratings by Morgan Stanley (David Risinger)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/26/2026 | Viatris | VTRS | Maintain | Underweight (N/A) |
|
Details | ||
| 5/9/2022 | Alkermes | ALKS | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/6/2022 | Eli Lilly | LLY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/24/2022 | Eli Lilly | LLY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2021 | Eli Lilly | LLY | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2021 | Organon & Co. | OGN | New Coverage | Equalweight (N/A) |
28.45 (13.73) |
-51.74% | Details | |
| 6/8/2021 | Eli Lilly | LLY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/28/2021 | Johnson & Johnson | JNJ | New Coverage | Overweight (N/A) |
168.81 (273.41) |
61.96% | Details | |
| 5/21/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/20/2021 | Bristol-Myers Squibb Co. | BMY | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/13/2021 | Phibro Animal Health Corp. | PAHC | Maintain | Underweight (Underweight) |
|
Details | ||
| 5/10/2021 | Pfizer | PFE | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 4/30/2021 | Bristol-Myers Squibb Co. | BMY | Downgrade | Equalweight (Overweight) |
66.03 (67.61) |
2.39% | Details | |
| 4/28/2021 | Eli Lilly | LLY | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/26/2021 | Bristol-Myers Squibb Co. | BMY | Maintain | Overweight (N/A) |
|
Details | ||
| 4/14/2021 | Abbvie | ABBV | Maintain | Overweight (N/A) |
|
Details | ||
| 4/1/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 4/1/2021 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 3/30/2021 | Abbvie | ABBV | Maintain | Overweight (N/A) |
|
Details | ||
| 3/22/2021 | Horizon Therapeutics | HZNP | New Coverage | Overweight (N/A) |
88.15 (116.30) |
31.93% | Details | |
| 3/10/2021 | Viatris | VTRS | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 3/8/2021 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 3/5/2021 | Eli Lilly | LLY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/5/2021 | Perrigo Co. | PRGO | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 3/3/2021 | Endo International plc | ENDP | Maintain | Underweight (Underweight) |
|
Details | ||
| 2/26/2021 | Bausch Health Companies | BHC | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/24/2021 | Eli Lilly | LLY | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2021 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/11/2021 | Abbvie | ABBV | Maintain | Overweight (N/A) |
|
Details | ||
| 2/4/2021 | Eli Lilly | LLY | Maintain | Overweight (Overweight) |
|
Details | ||
| 1/29/2021 | Pfizer | PFE | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 1/29/2021 | Jazz Pharmaceuticals | JAZZ | Downgrade | Equalweight (Overweight) |
163.95 (120.72) |
-26.37% | Details | |
| 1/28/2021 | Abbvie | ABBV | Maintain | Overweight (Overweight) |
|
Details | ||
| 1/22/2021 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 1/4/2021 | Bristol-Myers Squibb Co. | BMY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/21/2020 | Bristol-Myers Squibb Co. | BMY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/21/2020 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/21/2020 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 12/21/2020 | Eli Lilly | LLY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/21/2020 | Teva Pharma | TEVA | Maintain | Underweight (N/A) |
|
Details | ||
| 12/21/2020 | Endo International plc | ENDP | Maintain | Underweight (N/A) |
|
Details | ||
| 12/21/2020 | Bausch Health Companies | BHC | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/21/2020 | Amneal Pharmaceuticals | AMRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/21/2020 | Alkermes | ALKS | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/30/2020 | Abbvie | ABBV | Maintain | Overweight (N/A) |
|
Details | ||
| 11/23/2020 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/20/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2020 | Eli Lilly | LLY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/22/2020 | Abbvie | ABBV | Maintain | Overweight (N/A) |
|
Details | ||
| 10/14/2020 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/14/2020 | Bristol-Myers Squibb Co. | BMY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/7/2020 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/3/2020 | Eli Lilly | LLY | Upgrade | Overweight (Equalweight) |
147.30 (1280.34) |
769.21% | Details | |
| 8/20/2020 | Zoetis Inc. | ZTS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/20/2020 | Abbvie | ABBV | Maintain | Overweight (N/A) |
|
Details | ||
| 8/20/2020 | Elanco Animal Health | ELAN | Upgrade | Overweight (Equalweight) |
26.09 (24.50) |
-6.09% | Details | |
| 8/14/2020 | Eli Lilly | LLY | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/14/2020 | Bristol-Myers Squibb Co. | BMY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2020 | Bristol-Myers Squibb Co. | BMY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/10/2020 | Horizon Therapeutics | HZNP | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2020 | Jazz Pharmaceuticals | JAZZ | Upgrade | Overweight (Equalweight) |
122.24 (252.16) |
106.28% | Details | |
| 8/6/2020 | Phibro Animal Health Corp. | PAHC | Downgrade | Underweight (Equalweight) |
23.86 (35.44) |
48.53% | Details | |
| 7/31/2020 | Horizon Therapeutics | HZNP | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2020 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/21/2020 | Pfizer | PFE | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 7/13/2020 | Royalty Pharma | RPRX | New Coverage | Equalweight (N/A) |
48.36 (61.73) |
27.65% | Details | |
| 6/23/2020 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 5/11/2020 | Abbvie | ABBV | New Coverage | Overweight (N/A) |
83.96 (265.97) |
216.78% | Details | |
| 5/8/2020 | Horizon Therapeutics | HZNP | Maintain | Overweight (N/A) |
|
Details | ||
| 4/9/2020 | Eli Lilly | LLY | Downgrade | Equalweight (Overweight) |
141.88 (1280.34) |
802.41% | Details | |
| 4/2/2020 | Elanco Animal Health | ELAN | Downgrade | Equalweight (Overweight) |
20.15 (24.50) |
21.59% | Details | |
| 4/2/2020 | Bausch Health Companies | BHC | Downgrade | Equalweight (Overweight) |
13.75 (6.89) |
-49.89% | Details | |
| 4/2/2020 | Bristol-Myers Squibb Co. | BMY | Upgrade | Overweight (Overweight) |
54.82 (67.61) |
23.33% | Details | |
| 2/12/2020 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2020 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/7/2020 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2020 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 1/28/2020 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2020 | Mylan | MYL | Maintain | Equalweight (N/A) |
|
Details | ||
| 1/7/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Equalweight (N/A) |
|
Details | ||
| 1/7/2020 | Horizon Therapeutics | HZNP | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2020 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2020 | Amneal Pharmaceuticals | AMRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/18/2019 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/18/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/18/2019 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/18/2019 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 12/18/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/18/2019 | Eli Lilly | LLY | Upgrade | Overweight (Equalweight) |
122.85 (1280.34) |
942.2% | Details | |
| 12/16/2019 | Horizon Pharma | HZNP | Maintain | Overweight (N/A) |
|
Details | ||
| 11/22/2019 | Bristol-Myers Squibb Co. | BMY | New Coverage | Equalweight (N/A) |
56.85 (54.82) |
-3.57% | Details | |
| 11/7/2019 | Elanco Animal Health | ELAN | Upgrade | Overweight (Equalweight) |
27.43 (24.50) |
-10.68% | Details | |
| 11/7/2019 | Mylan | MYL | Downgrade | Equalweight (Overweight) |
17.79 (15.86) |
-10.85% | Details | |
| 9/30/2019 | Zoetis Inc. | ZTS | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/5/2019 | Phibro Animal Health Corp. | PAHC | Upgrade | Equalweight (Underweight) |
20.34 (35.44) |
74.24% | Details | |
| 9/5/2019 | Alkermes | ALKS | Upgrade | Equalweight (Underweight) |
19.99 (50.18) |
151.03% | Details | |
| 8/27/2019 | Pfizer | PFE | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/9/2019 | Mallinckrodt plc | MNK | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/30/2019 | Mylan | MYL | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2019 | Pfizer | PFE | Downgrade | Equalweight (Overweight) |
43.09 (51.24) |
18.91% | Details | |
| 7/15/2019 | Mylan | MYL | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2019 | Teva Pharma | TEVA | Downgrade | Underweight (Equalweight) |
8.97 (37.47) |
317.73% | Details | |
| 7/15/2019 | Endo International plc | ENDP | Downgrade | Underweight (Equalweight) |
3.96 (0.29) |
-92.68% | Details | |
| 6/21/2019 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 6/4/2019 | Pfizer | PFE | New Coverage | Overweight (N/A) |
41.92 (43.09) |
2.79% | Details | |
| 5/22/2019 | Mallinckrodt plc | MNK | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/8/2019 | Mylan | MYL | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2019 | Mylan | MYL | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/1/2019 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 3/26/2019 | Perrigo Co. | PRGO | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/13/2019 | Endo International plc | ENDP | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/13/2019 | Elanco Animal Health | ELAN | New Coverage | Equalweight (N/A) |
30.70 (24.50) |
-20.2% | Details | |
| 3/8/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/8/2019 | Horizon Pharma | HZNP | Upgrade | Overweight (Equalweight) |
25.82 (116.30) |
350.43% | Details | |
| 3/6/2019 | Mylan | MYL | Upgrade | Overweight (Equalweight) |
27.39 (15.86) |
-42.1% | Details | |
| 3/4/2019 | Horizon Pharma | HZNP | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/4/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/28/2019 | Mallinckrodt plc | MNK | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/15/2019 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2019 | Allergen | AGN | Downgrade | Equalweight (Overweight) |
158.69 (193.02) |
21.63% | Details | |
| 1/28/2019 | Abbvie | ABBV | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/20/2018 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 12/20/2018 | Bristol-Myers Squibb Co. | BMY | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/20/2018 | Allergen | AGN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/20/2018 | Abbvie | ABBV | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/14/2018 | Amneal Pharmaceuticals | AMRX | Downgrade | Equalweight (Overweight) |
16.58 (18.11) |
9.23% | Details | |
| 11/28/2018 | Jazz Pharmaceuticals | JAZZ | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/13/2018 | Perrigo Co. | PRGO | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/7/2018 | Abbvie | ABBV | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/6/2018 | Bristol-Myers Squibb Co. | BMY | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/6/2018 | Mylan | MYL | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/5/2018 | Bausch Health Companies | BHC | Upgrade | Overweight (Equalweight) |
24.78 (6.89) |
-72.2% | Details | |
| 11/5/2018 | Teva Pharma | TEVA | Upgrade | Overweight (Equalweight) |
23.00 (16.73) |
-27.26% | Details | |
| 11/2/2018 | Zoetis Inc. | ZTS | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/31/2018 | DepoMed Inc | ASRT | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/15/2018 | Elanco Animal Health | ELAN | New Coverage | Equalweight (N/A) |
32.39 (30.70) |
-5.22% | Details | |
| 10/9/2018 | Mylan | MYL | Downgrade | Equalweight (Overweight) |
35.29 (27.39) |
-22.39% | Details | |
| 10/3/2018 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/23/2018 | Allergen | AGN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/23/2018 | Merck | MRK | Maintain | Overweight (N/A) |
|
Details | ||
| 8/23/2018 | Pfizer | PFE | Maintain | Overweight (N/A) |
|
Details | ||
| 8/21/2018 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight () |
|
Details | ||
| 8/17/2018 | Mallinckrodt plc | MNK | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/17/2018 | Horizon Pharma | HZNP | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/17/2018 | Endo International plc | ENDP | Maintain | Equalweight (N/A) |
|
Details |
